2-Way Foley Catheter Market Size and Demand 2034
Global 2-Way Foley Catheter Market Growth, Size, Trends Analysis - By Material, By Indication, By Usage, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Nov-2025 | Report ID: MEDE2577 | Pages: 1 - 273 | Formats*: |
| Category : Medical Devices | |||
2-Way Foley Catheter Market Introduction and Overview
According to SPER Market Research, the Global 2-Way Foley Catheter Market is estimated to reach USD 488.34 million by 2034 with a CAGR of 5.71%.
The report includes an in-depth analysis of the Global 2-Way Foley Catheter Market, including market size and trends, product mix, Applications, and supplier analysis. The 2-way foley catheter market is expected to grow at a compound annual growth rate (CAGR) of 5.71% from 2025 to 2034, from an estimated USD 280.26 million in 2024. The increasing incidence of urological conditions like bladder cancer and incontinence, as well as the growing demand for minimally invasive procedures, are the main causes of this growth. Furthermore, it is projected that improvements in healthcare infrastructure, especially in developing nations, will support the market's growth.
By Material Insights
The global market is divided into two categories based on material: silicone foley catheters and latex foley catheters. Due to its distinctive qualities that improve patient comfort and lower the risk of infection, the silicone segment held the largest market share in 2024. In order to reduce the risk of catheter-related urinary tract infections (CAUTIs), these catheters are infused with silver ions, which inhibit microbial growth. Because of their smoothness and flexibility, silicone Foley catheters are non-allergic and perfect for people with sensitive skin. They also make insertion less painful. They are also more tissue-friendly and usually have larger lumens for better drainage, which makes them a popular option for long-term use and helps the segment expand.
By Indication Insights
The global market is classified into three categories based on indication: urinary incontinence, enlarged prostate gland/BPH and spinal cord injury. Over the course of the forecast period, the spinal cord injury (SCI) segment is anticipated to grow at the fastest CAGR. Because damage to the nerves that transmit signals from the bladder to the brain impairs the ability to empty the bladder, spinal cord injuries can interfere with the regulation of bladder function.
By Usage Insights
Based on usage, the global market is separated into two segments: short term use and long-term use. In 2024, the market was dominated by the short-term use segment. Catheterization for less than 30 days is generally considered short-term use; however, in order to reduce the risk of complications and infections, the European Association of Urology Nurses (EAUN) recommends a maximum duration of no more than 14 days. Over the course of the forecast period, this segment is expected to grow at the fastest rate. The growing number of hospitals stays and surgical procedures requiring temporary urine drainage is driving the short-term use segment. The need for short-duration catheterization solutions is also being driven by post-operative care protocols and an increase in acute urinary retention cases in healthcare settings.
By End Use Insights
Based on end use type, the global market is separated into two segments: hospitals and long-term care facilities. In 2024, the hospital segment had the biggest share. The need for more extensive surgical intervention has been primarily caused by an increase in the prevalence of urological diseases. Because of their extensive treatment options and ability to handle any emergencies that may arise during surgeries, hospitals are especially preferred for urological procedures and other related therapies. Hospitals draw more patients than other healthcare facilities because they are better suited to manage complicated cases and offer specialized care.
By Regional Insights
In 2024, the North American 2-way foley catheter market held the largest global revenue share, primarily due to specific medical scenarios like treating complex urological conditions like bladder fistulas or reconstructive surgeries, managing severe haematuria with continuous bladder irrigation, and managing postpartum haemorrhage using uterine tamponade. The region's sophisticated healthcare system, greater surgical rates, and emphasis on all-encompassing urological and maternal care support this demand.
Market Competitive Landscape
The 2-way Foley catheter market is fiercely competitive, with global med-device majors and agile regional manufacturers competing on antimicrobial/coatings and material innovation, regulatory approvals, pricing, and distribution partnerships, while buyers prioritize infection prevention, safety, and cost. Some of the key market players are AdvaCare Pharma, Advin Health Care, ANGIPLAST PRIVATE LIMITED, B. Braun SE, Bactiguard AB, Cardinal Health, Coloplast Corp., HEMC (Hospital Equipment Manufacturing Company), Medtronic, Sterimed Group.
Recent Developments:
In May 2024, Coloplast has launched the Luja catheter for women in four markets, including the United States and Europe. This expansion came after the successful introduction of a men's version in several global regions, which addressed specific needs for female patients with urinary incontinence. The launch aimed to improve women's comfort and discretion while managing these conditions.
In January 2023, Bactiguard received the first MDR (Medical Device Regulation 2017/745) approval in Europe for the latex BIP 2-way Foley Catheter. This approval followed a rigorous authorization process and represents a significant milestone for the company. The BIP 2-way Foley Catheter incorporates Bactiguard's patented infection prevention technology, which uses a thin noble metal alloy coating to reduce microbial adhesion, lowering the risk of healthcare-associated infections (HAIs) and catheter-associated urinary tract infections.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Material, By Indication, By Usage, By End Use |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | AdvaCare Pharma, Advin Health Care, ANGIPLAST PRIVATE LIMITED, B. Braun SE, Bactiguard AB, Cardinal Health, Coloplast Corp., HEMC (Hospital Equipment Manufacturing Company), Medtronic, Sterimed Group |
Key Topics Covered in the Report
- Global 2-Way Foley Catheter Market Size (FY’2021-FY’2034)
- Overview of Global 2-Way Foley Catheter Market
- Segmentation Global 2-Way Foley Catheter Market By Material (silicone foley catheters, latex foley catheters)
- Segmentation Global 2-Way Foley Catheter Market By Indication (urinary incontinence, enlarged prostate gland/BPH, spinal cord injury)
- Segmentation Global 2-Way Foley Catheter Market By Usage (short term use, long-term use)
- Segmentation Global 2-Way Foley Catheter Market By End Use (hospitals, long-term care facilities)
- Statistical Snap of Global 2-Way Foley Catheter Market
- Expansion Analysis of Global 2-Way Foley Catheter Market
- Problems and Obstacles in Global 2-Way Foley Catheter Market
- Competitive Landscape in the Global 2-Way Foley Catheter Market
- Details on Current Investment in Global 2-Way Foley Catheter Market
- Competitive Analysis of Global 2-Way Foley Catheter Market
- Prominent Players in the Global 2-Way Foley Catheter Market
- SWOT Analysis of Global 2-Way Foley Catheter Market
- Global 2-Way Foley Catheter Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.Introduction
1.1.Scope of the report1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data2.1.2.Primary Data2.1.3.SPERs internal database2.1.4.Premium insight from KOLs
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers4.1.2.Restraints4.1.3.Opportunities4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths5.1.2.Weaknesses5.1.3.Opportunities5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape5.2.2.Economic Landscape5.2.3.Social Landscape5.2.4.Technological Landscape5.2.5.Environmental Landscape5.2.6.Legal Landscape
5.3.PORTERs Five Forces
5.3.1.Bargaining power of suppliers5.3.2.Bargaining power of buyers5.3.3.Threat of Substitute5.3.4.Threat of new entrant5.3.5.Competitive rivalry
5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Global 2-Way Foley Catheter Market Manufacturing Base Distribution, Sales Area, Product Type6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global 2-Way Foley Catheter Market
7.Global 2-Way Foley Catheter Market, By Material 2021-2034 (USD Million)
7.1.Silicone Foley Catheters7.2.Latex Foley Catheters
8.Global 2-Way Foley Catheter Market, By Indication 2021-2034 (USD Million)
8.1.Urinary Incontinence8.2.Enlarged Prostate Gland/ BPH8.3.Spinal Cord Injury8.4.Others
9.Global 2-Way Foley Catheter Market, By Usage 2021-2034 (USD Million)
9.1.Short-Term Use9.2.Long-Term Use
10.Global 2-Way Foley Catheter Market, By End-Use 2021-2034 (USD Million)
10.1.Hospitals10.2.Long Term Care Facilities10.3.Others
11.Global 2-Way Foley Catheter Market 2021-2034 (USD Million)
11.1.Global 2-Way Foley Catheter Market Size and Market Share
12.Global 2-Way Foley Catheter Market, By Region, 2021-2034 (USD Million)
12.1.Asia-Pacific
12.1.1.Australia12.1.2.China12.1.3.India12.1.4.Japan12.1.5.South Korea12.1.6.Rest of Asia-Pacific
12.2.Europe
12.2.1.France12.2.2.Germany12.2.3.Italy12.2.4.Spain12.2.5.United Kingdom12.2.6.Rest of Europe
12.3.Middle East and Africa
12.3.1.Kingdom of Saudi Arabia12.3.2.United Arab Emirates12.3.3.Qatar12.3.4.South Africa12.3.5.Egypt12.3.6.Morocco12.3.7.Nigeria12.3.8.Rest of Middle-East and Africa
12.4.North America
12.4.1.Canada12.4.2.Mexico12.4.3.United States
12.5.Latin America
12.5.1.Argentina12.5.2.Brazil12.5.3.Rest of Latin America
13.Company Profile
13.1.AdvaCare Pharma
13.1.1.Company details13.1.2.Financial outlook13.1.3.Product summary13.1.4.Recent developments
13.2.Advin Health Care
13.2.1.Company details13.2.2.Financial outlook13.2.3.Product summary13.2.4.Recent developments
13.3.Angiplast Private Limited
13.3.1.Company details13.3.2.Financial outlook13.3.3.Product summary13.3.4.Recent developments
13.4.B. Braun SE
13.4.1.Company details13.4.2.Financial outlook13.4.3.Product summary13.4.4.Recent developments
13.5.Bactiguard AB
13.5.1.Company details13.5.2.Financial outlook13.5.3.Product summary13.5.4.Recent developments
13.6.Cardinal Health
13.6.1.Company details13.6.2.Financial outlook13.6.3.Product summary13.6.4.Recent developments
13.7.Coloplast Corp.
13.7.1.Company details13.7.2.Financial outlook13.7.3.Product summary13.7.4.Recent developments
13.8.HEMC (Hospital Equipment Manufacturing Company)
13.8.1.Company details13.8.2.Financial outlook13.8.3.Product summary13.8.4.Recent developments
13.9.Medtronic
13.9.1.Company details13.9.2.Financial outlook13.9.3.Product summary13.9.4.Recent developments
13.10.Sterimed Group
13.10.1.Company details13.10.2.Financial outlook13.10.3.Product summary13.10.4.Recent developments
13.11.Others
14.Conclusion
15.List of Abbreviations
16.Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
The report includes an in-depth analysis of the Global 2-Way Foley Catheter Market, including market size and trends, product mix, Applications, and supplier analysis.
2-Way Foley Catheter Market is projected to reach USD 488.34 million by 2034, growing at a CAGR of 5.71% during the forecast period.
2-Way Foley Catheter Market size from 2025. The Market is expected to reach USD 488.34 million by 2034, at a CAGR of 5.71% during the forecast period.
2-Way Foley Catheter Market CAGR of 5.71% during the forecast period.
You can get the sample pages by clicking the link - Click Here
2-Way Foley Catheter Market size is USD 488.34 million from 2025 to 2034.
2-Way Foley Catheter Market covered By Material, By Indication, By Usage, By End Use
The North America is anticipated to have the highest Market share in the 2-Way Foley Catheter Market.
AdvaCare Pharma, Advin Health Care, ANGIPLAST PRIVATE LIMITED, B. Braun SE, Bactiguard AB, Cardinal Health, Coloplast Corp., HEMC (Hospital Equipment Manufacturing Company), Medtronic, Sterimed Group
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
